A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.


Seventy patients with idiopathic syndromes were treated with maprotiline, a noradrenaline reuptake inhibitor, or clomipramine, a serotonin reuptake inhibitor in a 6-week, double-blind, randomized, multicenter trial. Fifty-two patients completed the double-blind phase. Overall, 50% of the patients improved. Significant decreases were seen not only in the… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.